Cialis is the drug with the ear-catching TV commercial. A man and a woman repose on their outdoor sun deck -- sitting in his-and-her bathtubs -- contemplating the countryside as an announcer intones about the drug's 36-hour window of opportunity and warns about the (rare) side effects of four-hour erections.
When you're the newest entrant in a pharmaceutical market, you need to capture the public's attention quickly. The people promoting Cialis -- the biotechnology company IcosA Strategic Decision
"The first launch advantage is a very powerful advantage in pharmaceutical marketing," said Leonard Blum, vice president of sales and marketing for Icos of Bothell, Wash., referring to the five-year-plus head start for Viagra and the three-month lead for Levitra. Because drug marketing depends on what the FDA allows on a drug's label, Eli Lilly and Icos decided to promote the drug's major distinction: It stays in the body longer than the competitors' drugs. Even the FDA remarks that Cialis is "different" than other medications because it can improve erectile function for up to 36 hours.TheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,890.46 | 1,351.95 | 2,927.23 | 20.47 |
Oil *
118.75
|
|
UP
6.51 |
UP
1.99 |
UP
11.37 |
UP
0.72 |
10 Yr
2.05%
SPDR Gold
168.02
|
|
+0.05%
|
+0.15%
|
+0.39%
|
+3.65%
|
Data delayed 20 minutes |

Connect with TheStreet